Annual information update

Hikma Pharmaceuticals Plc
14 May 2007



Annual Information Update

LONDON, 14 May 2007. In accordance with Prospectus Rule 5.2, Hikma
Pharmaceuticals PLC ('Hikma' or 'the Company')(LSE: HIK) (DIFX: HIK) sets out
below a summary of the information which has been published or made available to
the public over the previous 12 months. The information referred to in this
Update was up to date at the time the information was published, but some
information may now be out of date.

Stock Exchange announcements

Announcements made by the Company via RNS, a Regulatory Information Service, may
be viewed and downloaded from the London Stock Exchange website (
www.londonstockexchange.com/marketnews) or from the press releases page on the
Company's website at (http://investors.hikma.com/hikma/regulatorynews.jsp). The
London Stock Exchange announcements made during the defined period are:

Date of announcement              Headline of announcement
23 Apr 07                         Hikma appoints new CEO
20 Apr 07                         Hikma acquires Thymoorgan
05 Apr 07                         Block Listing 6-month review
05 Apr 07                         Notification of transaction
03 Apr 07                         LTIP awards
03 Apr 07                         Notification of transaction
03 Apr 07                         Notification of transaction
03 Apr 07                         Notification of transaction
03 Apr 07                         Notification of transaction
03 Apr 07                         Notification of transaction
02 Apr 07                         Notification of transaction
02 Apr 07                         Notification of transaction
02 Apr 07                         Notification of transaction
02 Apr 07                         Voting rights and capital
23 Mar 07                         Interest in shares
22 Mar 07                         Final Results - Part 3
22 Mar 07                         Final Results - Part 2
22 Mar 07                         Final Results - Part 1
26 Jan 07                         Completion of Acquisition
22 Jan 07                         Hikma enters oncology market
18 Jan 07                         Pre-close Trading Statement
21 Dec 06                         Voting rights and capital
12 Dec 06                         New board appointment
06 Dec 06                         Director's Commitments
27 Nov 06                         Notification of Transaction
22 Nov 06                         Renewal of Contract
20 Nov 06                         Notification of Site Visit
08 Nov 06                         Notification of transaction
03 Nov 06                         Section 198 Notification
27 Oct 06                         Section 198 Notification
24 Oct 06                         Trading update
09 Oct 06                         Block Listing 6-month review
03 Oct 06                         Notification of transaction
13 Sep 06                         Interim Results 2006 - Part 1
13 Sep 06                         Interim Results 2006 - Part 3
13 Sep 06                         Interim Results 2006 - Part 2
11 Sep 06                         Completion of Acquisition
13 Jul 06                         Section 198 Notification
13 Jul 06                         Pre-close Statement
21 Jun 06                         Director Transaction
12 Jun 06                         Section 198 Notification
31 May 06                         Director Transaction
25 May 06                         Results of AGM
25 May 06                         AGM Trading Statement
24 May 06                         Section 198 Notification
10 May 06                         Hikma releases info on DIFX
27 Apr 06                         Director/PDMR Shareholding

All of the above announcements were also made by the Company via the Dubai
International Financial Exchange ('DIFX') CANDI system. These announcements may
be viewed and downloaded from the DIFX website (www.difx.ae). Additional DIFX
announcements made during the defined period are:

26 Apr 2007          Notice of Annual Report and Accounts

Documents filed with the Financial Services Authority

The company has filed the following documents with the Financial Services
Authority ('FSA') over the previous 12 months. These documents are or will be
available to be viewed via the FSA's Document Viewing Facility or at the
Company's registered office.

Date filed with the FSA           Document filed with the FSA
26 Apr 2007                       2006 Annual Report and Accounts
26 Apr 2007                       Notice of Annual General Meeting

Documents filed with Companies House

The Company has made the following filings with Companies House. Copies of these
documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14
3UZ or, if you are a registered user, they may be viewed and downloaded using
Companies House Direct at www.direct.companieshouse.gov.uk. The Companies House
filings made during the defined period are:

Date filed with Companies        Document filed with Companies House
House
3 May 2007                       2006 Annual Report and Accounts
18 Apr 2007                      Form 88(2) - Return of Allotment of Shares
18 Apr 2007                      Form 88(2) - Return of Allotment of Shares
18 Apr 2007                      Form 88(2) - Return of Allotment of Shares
11 Apr 2007                      Form 88(2) - Return of Allotment of Shares
7 Feb 2007                       Form 88(2) - Return of Allotment of Shares
7 Feb 2007                       Form 88(2) - Return of Allotment of Shares
4 Jan 2007                       Form 288a - Appointment of Director
12 Oct 2006                      Form 88(2) - Return of Allotment of Shares
27 Sep 2006                      Form 363s - Annual Return
13 Sep 2006                      Interim Unaudited Accounts
12 July 2006                     Form 88(2) - Return of Allotment of Shares
12 July 2006                     Form 88(2) - Return of Allotment of Shares
25 May 2006                      Form 287 - Change of registered office
25 May 2006                      Ordinary and special resolutions passed at
                                 AGM
23 May 2006                      2005 Annual Report and Accounts
17 May 2006                      Form 88(2) - Return of Allotment of Shares
17 May 2006                      Form 88(2) - Return of Allotment of Shares



Henry Knowles
Company Secretary
14 May 2007
                                    - ENDS -

Enquiries:


Hikma Pharmaceuticals plc                               [phone]
Henry Knowles, Company Secretary
Susan Ringdal, Investor Relations Director
Brunswick Group LLP                                     [phone]
Jon Coles / Justine McIlroy / Alex Tweed

Notes to Editors

About Hikma
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and 
non-branded generic and in-licensed pharmaceutical products. Hikma's operations 
are conducted through three businesses: Generic, Branded and Injectable 
Pharmaceuticals. Hikma's operations are based principally in the Middle East
and North Africa ('MENA') region, the United States and Europe. In 2006, the
Group had revenue of $317 million and profit attributable to shareholders of 
$55 million. At 31 December 2006, the Group had over 2,443 employees. For news 
and other information, please visit www.hikma.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange